Anti-FcεR1α(human IgE receptor)monoclonal antibody (CRA2) Biotinylat ed IgG
DiagnoCine offers excellent Anti-FcεR1α | Human IgE (Immunoglobin E) receptor antibodies to researchers studying Allergic rhinitis treatment, Intranasal antihistamines, Intranasal corticosteroids, Leukotrienes, Subcutaneous immunotherapy, and Mechanisms & Treatment of Allergy.
Human diseases include Seasonal rhinitis, Atopic dermatitis, Anaphylaxis, Asthma, Dermatographia, and Physical Urticaria.
Anti-FcεR1α | Human IgE (Immunoglobin E) receptor antibody has excellent quality and this highly pure antibody can be adapted for Western Blots, ELISA, Immunohistochemistry, Immunofluorescence research with optimization.
General Information
| Cat. No. | :FNK-72-007 |
| Size | :50 ug |
| Antigen Species | :Human |
| Host Species | :Mouse |
| Cross Reactivity | :Human |
| Clone | :AER24 |
| Epitope | :Amino acids 85-172 of FcεR1α (Ref 3) |
| Isotype | :IgG1 (κ) |
| Application |
|
| Storage | :Shipped at 4℃ or -20℃ and stored at -20℃ |
| Form | :Purified monoclonal antibody (IgG) 1mg/ml in PBS (pH 7.4), 50% glycerol, filter-sterilized, azide-free |
| Data Link | :UniProtKB/Swiss-Prot P12319 (FCERA_HUMAN) |
Description
FcεR1α is a subunit of the high-affinity receptor for IgE to which IgE directly binds. FcεR1α is a tetrameric complex consisting of one α, one β, and two γ subunits. The latter two are required for signal transduction activity. The FcεR1 complex plays an important role in triggering allergic responses.
The CRA2 (AER24) monoclonal antibody reacts with the FcεR1α subunit on a region that overlaps the region of the IgE binding site, thus it competes with IgE for the receptor binding. Since the CRA1 (AER37) monoclonal antibody reacts with the site different from the IgE binding site on FcεR1α, it does not compete with IgE for the receptor binding. Combining the two antibodies, one can quantitatively measure the amounts of the IgE-bound FcεR1α.
The IgG fraction was purified from the serum-free culture medium of mouse hybridoma (CRA2) by propriety chromatography under mild conditions. This product is a biotinylated IgG ([biotin]/[IgG] = 6.9) produced from the IgG fraction.
Figure: FACS analysis of CHO/αβγ cells (1x105) with CRA1 and CRA2 antibodies by indirect-immunostaining using FITC-labeled secondary antibody. |
|
![]() |
References
Aliases for FCER1A Gene
